MangoRx Slim review: the oral-only GLP-1 specialist

Most GLP-1 telehealth companies started life as injection-first operations and added oral options later. MangoRx is the exception. Launched in 2022 as a men's health telehealth and expanding into weight loss in 2023, MangoRx built its GLP-1 program around orally dissolving tablets from day one — and they still don't offer injections. That's unusual enough to deserve a closer look.

Company background

MangoRx is operated by Mangoceuticals, Inc. (NASDAQ: MGRX), a publicly traded pharmaceutical company headquartered in Dallas, Texas. That matters for two reasons. First, public companies file quarterly financial statements and are subject to SEC disclosure requirements, which means there's a layer of financial transparency you don't get with most private telehealth operations. Second, MGRX's business is concentrated in a few product lines (men's health medications, hair loss, and weight loss), so their incentives and operations are relatively legible.

The company's weight loss program launched under the "Slim" brand in 2023 with compounded oral semaglutide. A companion product, "Trim," was added later for compounded oral tirzepatide. Both are ODT (orally dissolving tablet) formulations.

The products: Slim and Trim

Slim (compounded semaglutide ODT)

MangoRx Slim is a compounded semaglutide formulation delivered as an orally dissolving tablet. The tablet is flavored (citrus) and designed to dissolve on the tongue over 30–60 seconds. Dosing is flexible: the company offers starter doses as low as 1 mg and maintenance doses up to 6 mg, with titration protocols that roughly parallel FDA-approved injectable semaglutide.

Notable formulation detail: MangoRx's Slim includes vitamin B6 (pyridoxine) as a claimed nausea-mitigation additive. There's some (mixed) evidence that B6 helps with nausea from other causes — it's used for pregnancy-related nausea — and MangoRx has positioned this as a differentiator. Whether the B6 meaningfully reduces semaglutide-related GI side effects compared to compounded semaglutide without it is not established in published literature.

Trim (compounded tirzepatide ODT)

MangoRx Trim is marketed as compounded oral tirzepatide in ODT form. This deserves a blunt caveat that applies to every telehealth company selling "oral tirzepatide": tirzepatide is a 4,813-dalton peptide with no published human pharmacokinetic data supporting meaningful oral absorption. Eli Lilly itself chose not to develop an oral tirzepatide for exactly this reason, and instead developed the small-molecule orforglipron (Foundayo).

If you choose Trim, what you're actually getting is a compounded product with tirzepatide in it, delivered by an absorption route for which efficacy data in humans is essentially absent. This is the same issue facing every compounded oral tirzepatide on the market. We covered the details in our oral tirzepatide explainer.

Pricing

MangoRx publishes pricing plainly on their website (uncommon in this space — many competitors make you complete a consult before showing prices). Current monthly rates:

At $299/month for mainstream Slim dosing, MangoRx sits in the middle of the compounded oral semaglutide market — more expensive than bargain compounders like Wellorithm ($147/month) but cheaper than premium options. The flat rate includes the medication, clinical consults, and shipping.

Pharmacy partner: Epiq Scripts

MangoRx's dispensing pharmacy is Epiq Scripts, a compounding pharmacy with three accreditations worth noting:

• URAC — accreditation for pharmacy operations
• ACHC — accreditation for compounding pharmacy quality
• LegitScript — certification that the pharmacy operates legally and follows best practices

That's a solid accreditation stack. Not every compounding pharmacy has all three. Publicly identifying the pharmacy partner (as opposed to vaguely referring to "our pharmacy network") is itself a transparency signal.

Dosing and titration flexibility

One of Slim's genuine strengths is dose flexibility. Because the ODT format allows for smaller dose increments than injectable pens, MangoRx can offer fine-grained titration: 1 mg, 2 mg, 3 mg, 4 mg, and up to 6 mg semaglutide daily.

That matters for two types of patients:

• People who can't tolerate the standard titration (0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg weekly for injectable Wegovy) and need a slower ramp-up
• People on a maintenance dose who want to titrate down as they reach their goal weight, or up if they plateau

Fine dose control is a legitimate advantage of compounded ODT formulations in general — and MangoRx uses it more thoughtfully than most of its compounded competitors.

The telehealth experience

The signup flow follows the standard telehealth pattern: brief medical questionnaire, photos, identity verification, prescriber review, and (if approved) shipment of the first month. MangoRx's questionnaire is moderately rigorous — slightly more thorough than the lightest-touch compounders, slightly less than the most conservative medical platforms. Prescribers are licensed clinicians operating under state-appropriate supervision models.

Refills are automatic unless you cancel, which is standard telehealth practice and something to be aware of if you plan to use the service short-term.

Who MangoRx is best for

Editorial verdict

MangoRx is one of the better-operated compounded oral GLP-1 telehealth platforms. The public-company structure, named pharmacy partner, accreditation stack, and pricing transparency add up to a company that takes compliance more seriously than most of its competitors. The ODT format is also well-suited to patients who want oral but can't tolerate the strict fasting window of FDA-approved pills like the Wegovy tablet.

The honest caveats are the ones that apply to every compounded oral GLP-1: no FDA approval, no published human efficacy trials for ODT formulations specifically, and the regulatory risk any compounder faces in 2026. For Trim in particular (oral tirzepatide), the evidence base is thinner still.

If you want an oral-only GLP-1 provider and value transparency over rock-bottom pricing, MangoRx is a credible choice. Understand what "compounded" means, and you'll know what you're signing up for.

Alternatives to consider

If MangoRx isn't the right fit, here are three alternatives worth evaluating:

• Sesame Care — if you want FDA-approved oral GLP-1 (Wegovy pill, Rybelsus) instead of compounded, Sesame is the cleanest brand-name path
• SHED — if you want format variety (drops, lozenges, liposomal tablets, gummies) rather than ODT-only
• Wellorithm — if you want the same class of compounded oral semaglutide at roughly half the price, but with less transparency and less corporate scale